首页 | 本学科首页   官方微博 | 高级检索  
     


A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells
Authors:Yeh Elizabeth  Cunningham Melissa  Arnold Hugh  Chasse Dawn  Monteith Teresa  Ivaldi Giovanni  Hahn William C  Stukenberg P Todd  Shenolikar Shirish  Uchida Takafumi  Counter Christopher M  Nevins Joseph R  Means Anthony R  Sears Rosalie
Affiliation:Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
Abstract:The stability of c-Myc is regulated by multiple Ras effector pathways. Phosphorylation at Ser 62 stabilizes c-Myc, whereas subsequent phosphorylation at Thr 58 is required for its degradation. Here we show that Ser 62 is dephosphorylated by protein phosphatase 2A (PP2A) before ubiquitination of c-Myc, and that PP2A activity is regulated by the Pin1 prolyl isomerase. Furthermore, the absence of Pin1 or inhibition of PP2A stabilizes c-Myc. A stable c-Myc(T58A) mutant that cannot bind Pin1 or be dephosphorylated by PP2A replaces SV40 small T antigen in human cell transformation and tumorigenesis assays. Therefore, small T antigen, which inactivates PP2A, exerts its oncogenic potential by preventing dephosphorylation of c-Myc, resulting in c-Myc stabilization. Thus, Ras-dependent signalling cascades ensure transient and self-limiting accumulation of c-Myc, disruption of which contributes to human cell oncogenesis.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号